The negative expression of WT-1 and ER effectively excludes more common ovarian carcinoma types, such as high-grade serous carcinoma (typically WT-1+/ER+) and endometrioid carcinoma (typically ER+) (21, 22). This evidence concerns the gene WT1 and ovarian carcinoma.